BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Panés J, Gisbert JP. Eficacia de tofacitinib en el tratamiento de la colitis ulcerosa. Gastroenterología y Hepatología 2019;42:403-12. [DOI: 10.1016/j.gastrohep.2019.03.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Ahlawat S, Kumar P, Mohan H, Goyal S, Sharma KK. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Crit Rev Microbiol 2021;47:254-73. [PMID: 33576711 DOI: 10.1080/1040841X.2021.1876631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Fortuny Bauzá M, Cañete Pizarro F, Calm Salvans A, Calafat Sard M, Domènech Morral E. Tofacitinib for the treatment of acute severe ulcerative colitis refractory to infliximab. Gastroenterol Hepatol 2021:S0210-5705(21)00188-6. [PMID: 34118322 DOI: 10.1016/j.gastrohep.2021.05.005] [Reference Citation Analysis]
3 Chaparro M, Garre A, Mesonero F, Rodríguez C, Barreiro-de Acosta M, Martínez-cadilla J, Arroyo MT, Manceñido N, Sierra-ausín M, Vera-mendoza I, Casanova MJ, Nos P, González-muñoza C, Martínez T, Boscá-watts M, Calafat M, Busquets D, Girona E, Llaó J, Martín-arranz MD, Piqueras M, Ramos L, Surís G, Bermejo F, Carbajo AY, Casas-deza D, Fernández-clotet A, García MJ, Ginard D, Gutiérrez-casbas A, Hernández L, Lucendo AJ, Márquez L, Merino-ochoa O, Rancel FJ, Taxonera C, López Sanromán A, Rubio S, Domènech E, Gisbert JP. Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry. Journal of Crohn's and Colitis 2021;15:35-42. [DOI: 10.1093/ecco-jcc/jjaa145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Gisbert JP, Chaparro M. Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)? J Clin Med 2021;10:5318. [PMID: 34830595 DOI: 10.3390/jcm10225318] [Reference Citation Analysis]
5 Yang J, Liu X. Immunotherapy for Refractory Autoimmune Encephalitis. Front Immunol 2021;12:790962. [PMID: 34975890 DOI: 10.3389/fimmu.2021.790962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Liu YJ, Xu WH, Fan LM, Zhang YQ, Xu W, Chen YP, Chen LL, Chen L, Xu W, Wang Y, Chu KD, Zhang JP. Polydatin alleviates DSS- and TNBS-induced colitis by suppressing Th17 cell differentiation via directly inhibiting STAT3. Phytother Res 2022. [PMID: 35766233 DOI: 10.1002/ptr.7533] [Reference Citation Analysis]
7 Rogler G. Efficacy of JAK inhibitors in Crohn's Disease. J Crohns Colitis 2020;14:S746-54. [PMID: 31781755 DOI: 10.1093/ecco-jcc/jjz186] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
8 Klang E, Barash Y, Soffer S, Shachar E, Lahat A. Trends in inflammatory bowel disease treatment in the past two decades-a high-level text mining analysis of PubMed publications. United European Gastroenterol J 2021. [PMID: 34431607 DOI: 10.1002/ueg2.12138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Smail SW, Saeed M, Twana Alkasalias, Khudhur ZO, Younus DA, Rajab MF, Abdulahad WH, Hussain HI, Niaz K, Safdar M. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review. Food Chem Toxicol 2021;150:112087. [PMID: 33640537 DOI: 10.1016/j.fct.2021.112087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Singh PK, Lalwani LK, Govindagoudar MB, Aggarwal R, Chaudhry D, Kumar P, Gehlaut P. Tofacitinib Associated with Reduced Intubation Rates in the Management of Severe COVID-19 Pneumonia: A Preliminary Experience. Indian J Crit Care Med 2021;25:1108-12. [PMID: 34916741 DOI: 10.5005/jp-journals-10071-23964] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Gisbert JP, Chaparro M. Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review. Drugs 2020;80:1085-100. [PMID: 32562207 DOI: 10.1007/s40265-020-01346-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]